Log in to save to my catalogue

Mexiletine-Induced Esophageal Ulceration: Two Case Reports and a Review of the Literature

Mexiletine-Induced Esophageal Ulceration: Two Case Reports and a Review of the Literature

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eb6e1835ecbe49ecae34425ef1afec3a

Mexiletine-Induced Esophageal Ulceration: Two Case Reports and a Review of the Literature

About this item

Full title

Mexiletine-Induced Esophageal Ulceration: Two Case Reports and a Review of the Literature

Publisher

Switzerland: MDPI AG

Journal title

Reports (MDPI), 2025-01, Vol.8 (1), p.9

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Background and Clinical Significance: Mexiletine is a class 1B antiarrhythmic drug commonly prescribed for ventricular arrhythmias and neuropathic pain. It works as a blocker of the sodium channel that modulates cardiac conduction and reduces aberrant nerve signaling. While it is generally well tolerated, gastrointestinal side effects, such as naus...

Alternative Titles

Full title

Mexiletine-Induced Esophageal Ulceration: Two Case Reports and a Review of the Literature

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_eb6e1835ecbe49ecae34425ef1afec3a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eb6e1835ecbe49ecae34425ef1afec3a

Other Identifiers

ISSN

2571-841X

E-ISSN

2571-841X

DOI

10.3390/reports8010009

How to access this item